Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett's oesophagus

References

• Koop H, Schepp W, Muller-Lissner S, Madisch A, Micklefield G, Messmann H, et al. Consensus conference of the DGVS on gastroesophageal reflux. Z Gastroenterol 2005; 43: 163–4
   PubMed Web of Science ®Google Scholar
• Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888–95
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 2000; 119: 333–8
   PubMed Web of Science ®Google Scholar
• Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West. Gastroenterology 2002; 122: 588–95
   PubMed Web of Science ®Google Scholar
• Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000; 95: 1669–76
   PubMed Web of Science ®Google Scholar
• Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607–9
   PubMed Web of Science ®Google Scholar
• Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001; 120: 1630–9
   PubMed Web of Science ®Google Scholar
• Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993; 88: 1832–6
   PubMed Web of Science ®Google Scholar
• Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?. Ann Thorac Surg 1992; 54: 199–204
   PubMed Web of Science ®Google Scholar
• Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19: 166–78
   PubMed Web of Science ®Google Scholar
• Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001; 32: 368–78
   PubMed Web of Science ®Google Scholar
• Vieth M, Seitz G. 50 Jahre Barrett-Ösophagus. Pathologe 2001; 22: 62–71
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. Lyons: International Agency for Research on Cancer (IARC) Press; 2000. (World Health Organization classification of tumours.).
   Google Scholar
• Pech O, Gossner L, May A, Rabenstein T, Vieth M, Stolte M, et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 2005; 62: 24–30
   PubMed Web of Science ®Google Scholar
• Schouten HJA. Statistical measurement of interobserver agreement. 1st ed. Utrecht: Elinkwijk; 1985.
   Google Scholar
• Fleiss JL. Statistical methods for rates and proportion. 2nd ed. New York: John Wiley; 1981.
   Google Scholar
• Altman DG. Practical statistics for medical research. 1st ed. New York: Chapman and Hall; 1991.
   Google Scholar
• Streitz JM, Jr, Andrews CW, Jr, Ellis FH, Jr. Endoscopic surveillance of Barrett's esophagus. Does it help?. J Thorac Cardiovasc Surg 1993; 105: 383–7
   PubMed Web of Science ®Google Scholar
• Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108: 813–21
   PubMed Web of Science ®Google Scholar
• van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43: 216–22
   PubMed Web of Science ®Google Scholar
• van der Burgh A, Dees J, Hop WC, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996; 39: 5–8
   PubMed Web of Science ®Google Scholar
• Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. Br Med J 2000; 321: 1252–5
   PubMed Web of Science ®Google Scholar
• Canto MI, Setrakian S, Willis J, Chak A, Petras R, Powe NR, et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000; 51: 560–8
   PubMed Web of Science ®Google Scholar
• Sharma P, Weston AP, Topalovski M, Cherian R, Bhattacharyya A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003; 52: 24–7
   PubMed Web of Science ®Google Scholar
• Egger K, Werner M, Meining A, Ott R, Allescher HD, Hofler H, et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut 2003; 52: 18–23
   PubMed Web of Science ®Google Scholar
• Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000; 95: 3383–7
   PubMed Web of Science ®Google Scholar
• Morales CR, Souza RF, Spechler SJ. Hallmarks of cancer progression in Barrett's oesophagus. Lancet 2002; 360: 1587–9
   PubMed Web of Science ®Google Scholar
• Wijnhoven BP, Tilanus HW, Dinjens WN. Molecular biology of Barrett's adenocarcinoma. Ann Surg 2001; 233: 322–37
   PubMed Web of Science ®Google Scholar
• Flejou JF. Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut 2005; 54: 6–12
   PubMed Web of Science ®Google Scholar
• Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212–9
   PubMed Web of Science ®Google Scholar
• Fennerty MB, Sampliner RE, Way D, Riddell R, Steinbronn K, Garewal HS. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989; 97: 815–20
   PubMed Web of Science ®Google Scholar
• Chatelain D, Flejou JF. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Virchows Arch 2003; 442: 18–24
   PubMed Web of Science ®Google Scholar
• Weston AP, Banerjee SK, Sharma P, Tran TM, Richards R, Cherian R. p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression. Am J Gastroenterol 2001; 96: 1355–62
   PubMed Web of Science ®Google Scholar